The problem of patient compliance with treatment for respiratory infections

Patient compliance describes the degree, to which a patient follows treatment regimen. At present, non-compliance with medical recommendations is one of the key problems for outpatient practice. Even in case of respiratory infections, patients often violate the prescribed treatment regimen, which leads to growth of ineffective treatment cases, complications, and is also accompanied by a high risk of selection of drug-resistant infectious organisms and rise in expenditures for managing patients. The most common mistakes made by patients include the change by patients of the prescribed antibiotic dosing regimen and premature termination of antimicrobial therapy. Factors affecting patient compliance are extremely diverse. Among them are factors associated with treatment and a disease, patient-associated factors of «doctor - patient» contact, and demographic predictors of low compliance, drug dosage frequency. The most important factors affecting adherence to treatment are duration of therapy; drug tolerance/safety; dosage forms (tablets, syrup, sachet); patient confidence in medical recommendations (presence of «doctor - patient» relationship); severity of the disease; patient age and sex; social activity/employment of the patient; social status of the patient, level of education; marital status; presence of a concomitant pathology in the patient; presence of bad habits (smoking, alcohol) in the patient. The main factor affecting the compliance with therapy is the drug dosage frequency. It is known that compliance is highest, if a patient is required to take a single dose of the drug per day. Duration of therapy is another important factor affecting the patient compliance. For instance, pharmacotherapy for 7 days is characterized by better compliance compared to longer antibiotic treatment regimens. Methods of improving compliance with antimicrobial therapy: reduction in the drug dosage frequency; short courses of antibiotic therapy; favourable safety profile; the cost of the drug; a patient-friendly form of antibiotic dosage form; patient education, clear information of the patient; monitoring the treatment process (repeat visits, phone contacts, etc.). The most effective way to increase compliance is to use an antibiotic drug 1-2 times per day. The use of short antibiotics courses (less than 7 days) is also a good way to increase adherence to treatment. The use of antibiotics with a good safety profile is another important approach to improving the compliance. The article also discusses other ways to enhance the patient compliance with the treatment for respiratory infections.

compliance, antibiotic therapy, respiratory tract infections

1. Pechere J.C., Hughes D., Kardas P., Cornaglia G. Non compliance with antibiotic therapy for acute community infections: a global survey. Int J Antimicrob Agents. 2007;29(3):245-253. doi: 10.1016/j.ijantimicag.2006.09.026.

2. Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother. 2002;49(6):897-903. doi: 10.1093/jac/dkf046.

3. Sinopalnikov A.I., Zaitsev A.A. Patient Compliance with Antimicrobial Therapy of Lower Respiratory Tract Infections. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy (CMAC). 2008;10(1):50-59. (In Russ.) Available at: https://elibrary.ru/item.asp?id=11575741.

4. Cockburn J., Reid A.L., Bowman J., SansonFisher R. Effects of intervention on antibiotic compliance in patients in general practice. Med J Aust. 1987;147(7):324-328. Available at: https://www.ncbi.nlm.nih.gov/pubmed/3498877.

5. Zaitsev A.A., Klochkov O.I., Sinopalnikov A.I. Treatment for community-acquired pneumonia in military personnel in the inpatient setting (pharmacoeconomic analysis). Klinitsist = The Clinician. 2007;(4):22-28. (In Russ.) available at: https://elibrary.ru/item.asp?id=13622040.

6. Favre O., Delacrétaz E., Badan M., Glauser M., Waeber B. Relationship between the prescriber’s instructions and compliance with antibiotherapy in outpatients treated for an acute infectious disease. J Clin Pharmacol. 1997;37(3):175-178. doi: 10.1002/j.1552-4604.1997.tb04778.x.

7. Branthwaite A., Pechere J.C. Pan-European survey of patients’ attitudes to antibiotics and antibiotic use. J Int Med Res. 1996;24(3):229-238. doi: 10.1177/030006059602400301.

8. Greenberg R.N. Overview of patient compliance with medication dosing: a literature review. Clin Ther. 1984;6(5):592-599. Available at: https://www.ncbi.nlm.nih.gov/pubmed/6383611.

9. Sclar D.A., Tartaglione T.A., Fine M.J. Overview of issues related to medical compliance with implications for outpatient management of infectious diseases. Infect Agents Dis. 1994;3(5):266-273. Available at: https://www. ncbi.nlm.nih.gov/pubmed/7866659.

10. Kardas P. Compliance to antibiotics in outpatients treated for respiratory infections. Pneumonol Alergol Pol. 1999;67(9-10):398- 408. Available at: https://www.ncbi.nlm.nih.gov/pubmed/10808383.

11. Ellerbeck E., Khallaf N., el Ansary K.S., Moursi S., Black R. Caretaker compliance with different antibiotic formula tions for treatment of childhood pneumonia. J Trop Pediatr. 1995;41(2):103-108. doi: 10.1093/tropej/41.2.103.

12. Guay D. Short-course antimicrobial therapy of respiratory tract infections. Drugs. 2003;63(20):2169-2184. doi: 10.2165/00003495-200363200-00002.

13. Lima J., Nazarian L., Charney E., Lahti C. Compliance with short-term antimicrobial therapy: some techniques that help. Pediatrics. 1976;57(3):383-386. Available at: https://www.ncbi.nlm.nih.gov/pubmed/1256949.

14. Dimopoulos G., Matthaiou D.K., Karageorgopoulos D.E., Grammatikos A.P., Athanassa Z., Falagas M.E. Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs. 2008;68(13):1841-1854. doi: 10.2165/00003495-200868130-00004.

15. Sinopalnikov A.I., Zaicev A.A. Clinical efficacy and safety of step-wise azithromycin monotherapy in patients with community-acquired pneumonia in a hospital. Pharmateca = Farmateka. 2006;(16):11. (In Russ.) Available at: https://pharmateca.ru/ru/archive/article/6667.

16. Li J., Winston L., Moore D., Bent S. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Am J Med. 2007;120(9):783-790. doi: 10.1016/j.amjmed.2007.04.023.

17. Torres A., Liapikou A. Levofloxacin for the treatment of respiratory tract infections. Expert Opin Pharmacother. 2012;13(8):1203-1212. doi: 10.1517/14656566.2012.688952.

18. Zanel G., Noreddin A.M. Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections. Curr Opin Pharmacol. 2001;1(5):459-463. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11764770.

19. Chien S., Wrong F., Fowler C.L., Callery-D’Amico S.V., Williams R.R., Nayak R., Chow A.T. Double-blind evaluation of safety and pharmacokinetics of multiple oral once-daily 750-mg and 1-gram doses of levofloxacin in healthy volunteers. Antimicrob Agents Chemother. 1998;42(4):885-888. Available at: https://www.ncbi.nlm.nih.gov/pubmed/9559801.